Cargando…
P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING VENETOCLAX WITH NON-INTENSIVE CHEMOTHERAPY
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429491/ http://dx.doi.org/10.1097/01.HS9.0000968948.19815.ef |
_version_ | 1785090727846346752 |
---|---|
author | Krüger, Katja Wichmann, Martin Gabdoulline, Razif Götze, Katharina Braitsch, Krischan Modemann, Franziska Fiedler, Walter Trummer, Arne Krauter, Jürgen Kaun, Stephan Rotermund, Susanne Voß, Andreas Goehring, Gudrun Behrens, Yvonne Thol, Felicitas Eder, Matthias Beutel, Gernot Stadler, Michael Heuser, Michael Shahswar, Rabia |
author_facet | Krüger, Katja Wichmann, Martin Gabdoulline, Razif Götze, Katharina Braitsch, Krischan Modemann, Franziska Fiedler, Walter Trummer, Arne Krauter, Jürgen Kaun, Stephan Rotermund, Susanne Voß, Andreas Goehring, Gudrun Behrens, Yvonne Thol, Felicitas Eder, Matthias Beutel, Gernot Stadler, Michael Heuser, Michael Shahswar, Rabia |
author_sort | Krüger, Katja |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429491 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104294912023-08-17 P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING VENETOCLAX WITH NON-INTENSIVE CHEMOTHERAPY Krüger, Katja Wichmann, Martin Gabdoulline, Razif Götze, Katharina Braitsch, Krischan Modemann, Franziska Fiedler, Walter Trummer, Arne Krauter, Jürgen Kaun, Stephan Rotermund, Susanne Voß, Andreas Goehring, Gudrun Behrens, Yvonne Thol, Felicitas Eder, Matthias Beutel, Gernot Stadler, Michael Heuser, Michael Shahswar, Rabia Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429491/ http://dx.doi.org/10.1097/01.HS9.0000968948.19815.ef Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Krüger, Katja Wichmann, Martin Gabdoulline, Razif Götze, Katharina Braitsch, Krischan Modemann, Franziska Fiedler, Walter Trummer, Arne Krauter, Jürgen Kaun, Stephan Rotermund, Susanne Voß, Andreas Goehring, Gudrun Behrens, Yvonne Thol, Felicitas Eder, Matthias Beutel, Gernot Stadler, Michael Heuser, Michael Shahswar, Rabia P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING VENETOCLAX WITH NON-INTENSIVE CHEMOTHERAPY |
title | P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING VENETOCLAX WITH NON-INTENSIVE CHEMOTHERAPY |
title_full | P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING VENETOCLAX WITH NON-INTENSIVE CHEMOTHERAPY |
title_fullStr | P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING VENETOCLAX WITH NON-INTENSIVE CHEMOTHERAPY |
title_full_unstemmed | P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING VENETOCLAX WITH NON-INTENSIVE CHEMOTHERAPY |
title_short | P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING VENETOCLAX WITH NON-INTENSIVE CHEMOTHERAPY |
title_sort | p510: predictors of response and outcome in patients with refractory/relapsed acute myeloid leukemia receiving venetoclax with non-intensive chemotherapy |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429491/ http://dx.doi.org/10.1097/01.HS9.0000968948.19815.ef |
work_keys_str_mv | AT krugerkatja p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT wichmannmartin p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT gabdoullinerazif p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT gotzekatharina p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT braitschkrischan p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT modemannfranziska p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT fiedlerwalter p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT trummerarne p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT krauterjurgen p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT kaunstephan p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT rotermundsusanne p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT voßandreas p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT goehringgudrun p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT behrensyvonne p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT tholfelicitas p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT edermatthias p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT beutelgernot p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT stadlermichael p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT heusermichael p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy AT shahswarrabia p510predictorsofresponseandoutcomeinpatientswithrefractoryrelapsedacutemyeloidleukemiareceivingvenetoclaxwithnonintensivechemotherapy |